Prenatal PFAS Exposure Increases Risk Of Liver Injury To Newborns: Study
A new study links PFAS exposure during pregnancy to an increased risk of childhood liver damage.
A new study links PFAS exposure during pregnancy to an increased risk of childhood liver damage.
The FDA is adding a new black box label warning to labels of Ocaliva, following reports of at least 19 deaths linked to incorrect dosing and severe liver injury.
A Limbrel recall comes about a month after the FDA began pressuring Primus Pharmaceuticals to remove the osteoarthritis medical food products from the market following reports of liver injury and…
The FDA is urging consumers not to use Limbrel, capsules marketed as medical food for the treatment of osteoarthritis, due to liver and hypersensitivity risks. It has also called for…
Federal health regulators have launched an investigation into a potential risk of serious and potentially life threatening side effects with Limbrel, indicating that reports have been received involving liver injury…
The FDA is warning that the liver disease drug Ocaliva has been linked to cases of severe liver injury and death when inappropriate doses have been prescribed.
A woman has been awarded $2 million in a medical malpractice lawsuit after she suffered permanent injuries during a gallbladder removal procedure.
Consumer Reports is warning consumers to stay away from dietary supplements for body building and that include green tea extract, due to an increasing risk of liver injury.
A shareholder lawsuit against the makers of the MS drug Tecfidera claims the company knew there were safety problems with the drug, but misrepresented its value to investors.
New label warnings indicate that the side effects of Tecfidera could cause liver injuries requiring hospitalization.